ZEB1 and cancer: Recent studies suggest an important role of EMT in resistance to gemcitabine, 5-FU, and cisplatin, which can be reversed by silencing of ZEB1 (Zinc finger E-box-binding homeobox 1) in resistant PDAC cancer cell lines [78, 79].